Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Calprotectin starves Pseudomonas aeruginosa of essential metals, affecting its growth and resistance.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

The model helps understand alopecia areata and suggests ways to improve treatment by targeting immune issues.

The model helps understand alopecia areata and suggests treatment strategies.

The model helps understand alopecia areata and suggests better treatment strategies.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Older skin has higher cancer risk due to inflammation and stem cell issues.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.